The sphingosine 1-phosphate receptor 2 (S1PR2), along with insulin, plays an important role in the regulation of nutrient metabolism in the liver. Following a meal, conjugated bile acids (CBAs) returning to the liver bind to S1PR2 activating both the ERK1/2 and AKT (insulin signaling pathway). Activation of the insulin signaling pathway by CBAs and insulin activates phosphoinositide-dependent protein kinase 1 (PDK1), which activates protein kinase C *ζ* (PKC*ζ*). PKC*ζ* then phosphorylates the farnesoid X receptor (FXR) allowing it to translocate to the nucleus. FXR is activated by bile acids causing the induction of a number of genes involved in bile acid metabolism and transport. Bile acids induce the gene encoding the short heterodimeric partner (SHP). SHP is a nuclear receptor, without a DNA binding domain, and functions much like a dominant-negative protein by interacting with other nuclear receptors (HNF4*α*, LRH-1 and others) to inhibit their functions. HNF4*α* is also an important regulator of nutrient metabolism in the liver. PKC*ζ* also regulates the movement of the basolateral bile acid transporter (NTCP) and canalicular membrane transporter (BSEP) to their respective membranes. Activated AKT increases glycogen synthesis and inhibits glucose synthesis by down-regulating the genes encoding the gluconeogenic genes, PEPCK and G-6-Pase, and activating glycogen synthase activity, respectively. S1PR2 also activates nuclear sphingosine kinase 2 (SphK2) increasing the concentration of S1P in the nucleus, a powerful inhibitor of histone deacetylase 1 and 2 (HDAC 1/2). Inhibition of HDAC 1/2 allows for increased histone acetylation and increased differential induction of genes encoding enzyme and nuclear receptors involved in regulating nutrient metabolism in the liver. In this manner, bile acids function as nutrient signaling molecules in the liver to regulate metabolism.

Model for the role of sphingosine 1-phosphate receptor 2 in regulating nutrient metabolism in the liver. *Abbreviations*: S1PR2, sphingosine 1-phosphate receptor 2; TCA, taurocholate; Src, Src kinase; EGFR, epidermal growth factor receptor; PI3K, phosphoinositide-3-kinase; PKC*ζ*, protein kinase C zeta; PPAR*α*, peroxisome proliferator-activated receptor alpha; FXR, farnesoid X receptor; SHP, short heterodimeric partner; NTCP, Na^+^/taurocholate co-transporting polypeptide; BSEP, bile salt export pump; PC, phosphotidylcholine; PEPCK, phosphoenolpyruvate carboxykinase; G-6-Pase, glucose-6-phosphatase; PDK1, phosphoinositide-dependent protein kinase 1; AKT, protein kinase B; SREBP, sterol regulatory element-binding protein.
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